Skip to content

MIST - Milestone Pharmaceuticals Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchM

Milestone Pharmaceuticals Inc

MIST · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

M

MISTMilestone Pharmaceuticals Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $3.06
52-wk low: $1.00
Prev close: $2.23
Mkt cap: $134.5M
Beta: 0.98
P/S: 57.4x

Smart money

8 funds hold a position and insiders have been net selling.

Real smart money

Funds holding this stock

8 holders

Combined position$17.6M

P7
Point72
Steven Cohen · Q2 2026 13F
$7.3M
position
MI
Millennium
Israel Englander · Q2 2026 13F

Earnings

Reported Aug 12, 2026

Earnings came in 16.7% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $134M

Valuation

P/S57.39
P/B7.31

Quality

Operating margin-4585.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: MIST
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $134.46M
Beta: 0.98

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

7.3x

Profit margin

+0.0%

Op margin

-4585.0%

ROE

-35523.0%

$4.2M

position

TS

Two Sigma

Q2 2026 13F

$2.7M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for MIST

No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.21-16.7%

-$0.18 expected

Next report

What the street expects next

EPS expected

-$0.21

-$0.26 to -$0.18

Revenue expected

$1.6M

6 analysts

Last 30 days

1up2down

Analysts cutting estimates

-35523.0%

ROA-42.8%

Growth

Beta0.98